Brief: Nuvation Bio Q1 EPS USD -0.16
07/05/2025 21:05
May 07 (Reuters) - Nuvation Bio Q1 operating expenses USD 59.994 million. Q1 net income USD -53.236 million Q1 pretax profit USD -53.236 million Q1 operating profit USD -59.004 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth